Juan Huaccho-Rojas

Juan Huaccho-Rojas

Auto-generated profile, based on publicly available information

Juan Huaccho-Rojas

Facultad de Medicina Humana, Universidad Científica del Sur, Lima, Perú; CHANGE Research Working Group, Carrera de Medicina Humana, Facultad de Ciencias de la Salud, Universidad Científica del Sur, Lima, Perú

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2026 in Medical Education & Clinical Practice
Verified
Journal Article
Open access
AÑAlvaro M. Ñaña-Cordova
Alvaro M. Ñaña-Cordova
FZFrank Zela-Coila
Frank Zela-Coila
Mabel R. Challapa-MamaniMabel R. Challapa-Mamani
Mabel R. Challapa-Mamani
SLStefani Laureano-Condori
Stefani Laureano-Condori
DIDina Vanesa Ito-Larico
Dina Vanesa Ito-Larico
JHJuan Huaccho-Rojas
Juan Huaccho-Rojas
Objective: Describe the characteristics of organizational management, research activities, and perceived barriers of medical student scientific societies affiliated with SOCIMEP during the last quarter of 2024. Methods: Observational, descriptive, cross-sectional study involving the 41 SOCEMs affiliated with SOCIMEP during the last quarter of 2024. A virtual survey was applied to their representatives, collecting data on organization, institutional support, academic activities, and scientific output. Descriptive analysis included absolute frequencies, means, and standard deviations. Results: Responses were obtained from 37 SOCEMs (90.2%). Of these, 64.86% had an advisory board and 91.89% collaborated with other SOCEMs. Only 18.92% received financial support. A total of 64.86% were conducting research projects and 54.05% had published in the last year. Individually, 66.67% of representatives had started extracurricular research, but only 33.33% published. Main needs identified were training in scientific writing (89.39%), research methodology (69.70%), and greater institutional and financial support. Conclusions: Peruvian SOCEMs show a high level of collaboration and interest in research, but face limitations in funding, mentoring, and scientific production. These gaps could affect their sustainability. It is a priority to strengthen their institutional structure, methodological training, and publication support to enhance the research training of medical students in Peru.

18 June 2025 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Closed access
JHJuan Huaccho-Rojas
Juan Huaccho-Rojas
LULeonardo J. Uribe-Cavero
Leonardo J. Uribe-Cavero
ADAngie Diaz-Mejía
Angie Diaz-Mejía
Mabel R. Challapa-MamaniMabel R. Challapa-Mamani
Mabel R. Challapa-Mamani
MCMarisella Chumán-Sánchez
Marisella Chumán-Sánchez
MVMartha Villar-López
Martha Villar-López
Objectives: Traditional, Alternative, and Complementary Medicine (T&CM) encompasses a variety of health practices that differ from the conventional medical system, including the use of medicinal herbs and complementary therapies. In Peru, these practices, particularly the use of therapeutic plants, are legally protected and commonly used for treating certain conditions. However, the lack of inclusion of T&CM in medical education puts these practices at risk of disappearing. To analyze the inclusion of T&CM courses in the curricula of medical schools in Peru to identify gaps and opportunities for improving medical education and ensuring comprehensive training for future healthcare professionals. Methods: A cross-sectional study was conducted by reviewing the curricula of 47 Peruvian medical schools. Data on the presence, structure, and content of T&CM courses were extracted and analyzed descriptively. Results: In 2024, 15 out of 47 Peruvian universities offering Human Medicine programs (31.9 %) included T&CM courses. Among them, 73 % were public institutions, and 53 % were located in coastal regions. The most common topics were Traditional Chinese Medicine (93.3 %), Traditional Peruvian Medicine (87 %), phytotherapy (93 %), and acupuncture (80 %). Course structure varied: 60 % of courses were elective, while 40 % were mandatory. Most universities (93 %) allocated 2–3 academic credits, and 80 % incorporated practical training, though structured field visits were rare (6.7 %). Additionally, 53 % of universities included research activities. The lack of standardized curricular guidelines led to variability in course content and depth across institutions. Conclusions: Few universities in Peru teach T&CM, highlighting a need to enhance medical education. Increasing T&CM topics in curricula and addressing information access disparities are crucial.

10 June 2020 in Revista Peruana de Medicina Integrativa
Verified
Journal Article
Open access
PDF file
MSMarisol Sánchez-Yactayo
Marisol Sánchez-Yactayo
JVJosé Vallejos-Gamboa
José Vallejos-Gamboa
JHJuan Huaccho-Rojas
Juan Huaccho-Rojas
Objetivos. Determinar los factores asociados al uso de plantas medicinales en gestantes del Hospital Rezola de Cañete en el año 2019. Materiales y métodos. Diseño no experimental, tipo básico, nivel correlacional - transversal, método inductivo; la muestra estuvo conformada por 335 gestantes del Hospital Rezola de Cañete atendidas en el consultorio de ginecoobstetricia y a quienes se le aplicó la encuesta. Resultados. El 88,4% de las gestantes usaron plantas medicinales; el 11,6% no usó plantas medicinales. Entre los factores socioculturales y obstétricos referentes al uso de plantas medicinales se encuentra la edad (p= 12,41); el grado de instrucción (p= 12,35); el número de gestaciones previas (p= 27,63); el lugar de nacimiento (p= 5,09). El factor no asociado fue el lugar de procedencia (p= 3,676). Las plantas más usadas fueron la manzanilla 95%; el anís 65%; el té 58%; la hierba luisa 51%, y la malva 33%. Discusión. La mayoría de las gestantes del Hospital Rezola de Cañete que usaron plantas medicinales manifestaron resultados favorables y no observaron complicación alguna.

30 September 2025 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Closed access
JHJuan Huaccho-Rojas
Juan Huaccho-Rojas
TSThalia Camila Suárez-Hernández
Thalia Camila Suárez-Hernández
GSGiancarlo Jesús Solano-Garay
Giancarlo Jesús Solano-Garay
LLLuis Lens-Sardón
Luis Lens-Sardón
Introduction: Diabetes mellitus (DM) requires complementary therapies. Objectives: To determine the hypoglycemic effect of Blechnum asplenioides extract and its interaction with metformin in albino rats with induced DM. Methods: A controlled preclinical experimental study was conducted in a murine model using 72 Holtzman albino rats, randomly assigned to nine groups of eight animals each. Hyperglycemia was induced with alloxan 180 mg/kg. Treatments included metformin at 100 and 200 mg/kg, hydroalcoholic extract of Blechnum asplenioides at 250 and 500 mg/kg, and the respective combinations. Blood glucose (mg/dL) was measured by tail puncture at 1, 2, 6, and 24 hours. Means were compared using ANOVA with Tukey’s post hoc test. Results: Significant differences among groups were observed at all time points (p<0.05). At one hour, groups treated with Blechnum asplenioides 250 and 500 mg/kg, and the combination of Blechnum asplenioides 250 mg/kg plus metformin 100 mg/kg, showed reduced glucose levels compared with the untreated group. At two and six hours, most regimens produced significant decreases versus the untreated group. At 24 hours, Blechnum asplenioides 500 mg/kg, 250 mg/kg plus metformin 100 mg/kg, 250 mg/kg plus metformin 200 mg/kg, and 500 mg/kg plus metformin 200 mg/kg showed significant reductions compared with the untreated group (p<0.05); the last two were lower than the metformin 200 mg/kg group (p<0.05). No differences were observed compared with metformin 100 mg/kg at any measurement time. Conclusion: The hydroalcoholic extract of Blechnum asplenioides exerts hypoglycemic activity and, in combination with metformin, enhances glucose reduction, suggesting an additive effect.

19 October 2026 in European Journal of Integrative Medicine
Verified
Journal Article
Closed access
JHJ.J. Huaccho-Rojas
J.J. Huaccho-Rojas
CRCristian Carey Rivas
Cristian Carey Rivas
RVRosa Manrique Vertiz
Rosa Manrique Vertiz
NSNatalie Sosa-Tafur
Natalie Sosa-Tafur

28 June 2021 in Perspectivas en Nutrición Humana
Verified
Journal Article
Open access
PDF file
JRJuan Jesus Huaccho Rojas
Juan Jesus Huaccho Rojas
WTWendy Marjorie Yánac Tellería
Wendy Marjorie Yánac Tellería
AQAlfonso David Balladares Quintana
Alfonso David Balladares Quintana
LMLidsey Carolay Rodriguez Manyari
Lidsey Carolay Rodriguez Manyari
SPSol Jimena Galarza Puertas
Sol Jimena Galarza Puertas
MLMartha Villar López
Martha Villar López
Antecedentes: los tratamientos con base en medicamentos contra la COVID-19 no han sido aprobados hasta la actualidad. La forma más efectiva de enfrentar este problema de salud pública es la prevención con una adecuada alimentación, medidas de higiene y protección. Los alimentos han sido históricamente utilizados por la población para mejorar su nutrición y complementar el tratamiento o prevención de enfermedades. Se conocen los diversos compuestos bioactivos de algunos alimentos, que en estudios experimentales demostraron su acción antiviral e inmunomoduladora. Objetivo: identificar los compuestos bioactivos o preparados de alimentos con potencial efecto inmunomodulador, inmunoestimulante y antiviral contra el coronavirus. Materiales y métodos: se realizó una búsqueda en Google Scholar, Scopus y en la Biblioteca Virtual de Salud en Bases de datos de Medicina Tradicional, Complementaria e Integrativa utilizando los términos food, immunomodulatory, immunostimulatory y anti­viral en cuatro búsquedas sucesivas. Resultados: se obtuvieron 93 artículos y se identificó mayor evidencia sobre el efecto antiviral e inmunológico contra el coronavirus en nueve alimentos: Allium sativum, Cinnamomum zeylanicum, Citrus sinensis, Zingiber officinale, Vitis vinífera, Allium cepa, Curcuma longa, Punica granatum y Sambucus nigra. Los cuatro primeros mostraron actividad contra el SARS-CoV-2. Conclusiones: se evidenció el efecto inmunológico y antiviral contra el coronavirus de nueve alimentos; sin embargo, son estudios in silico e in vitro, por ello se requiere mayor investigación preclínica y clínica que lo confirmen.